These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Biobusiness on campus: commercialization of university-developed biomedical technologies. Dueker KS. Food Drug Law J; 1997 Nov 12; 52(4):453-509. PubMed ID: 10346675 [No Abstract] [Full Text] [Related]
54. Irish government under fire for turning its back on basic research. Butler D. Nature; 2015 Mar 19; 519(7543):273. PubMed ID: 25788075 [No Abstract] [Full Text] [Related]
55. The calculus of national medical research policy--the United States versus Asia. Sun GH, Steinberg JD, Jagsi R. N Engl J Med; 2012 Aug 23; 367(8):687-90. PubMed ID: 22913678 [No Abstract] [Full Text] [Related]
56. A return to order. Nature; 2014 Jan 23; 505(7484):453-4. PubMed ID: 24459718 [No Abstract] [Full Text] [Related]
57. An eye on the federal budget. Jennings CP. Nurs Spectr (Wash D C); 1998 Mar 09; 8(5):10. PubMed ID: 10542693 [No Abstract] [Full Text] [Related]
58. Republican win sparks fears for science funds. Brumfiel G. Nature; 2002 Nov 14; 420(6912):113. PubMed ID: 12432355 [No Abstract] [Full Text] [Related]
59. Is disclosure of potential conflicts of interest in medicine and public health sufficient to increase transparency and decrease corruption? Spelsberg A, Martiny A, Schoenhoefer PS, Working Group on Health of Transparency International, German Chapter. J Epidemiol Community Health; 2009 Aug 14; 63(8):603-5. PubMed ID: 19596840 [No Abstract] [Full Text] [Related]
60. Startups hope federal study fixes SBIR flaws. Basu P. Nat Biotechnol; 2004 Jun 14; 22(6):644. PubMed ID: 15175671 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]